Journal Article Research Support, N.I.H., Extramural Epublish 40 citations
PubMed: 35061039 DOI: 10.1001/jamanetworkopen.2021.44391
Association Between Laparoscopically Confirmed Endometriosis and Risk of Early Natural Menopause.
JAMA Netw Open 5(1):e2144391
Authors: Madhavi Thombre Kulkarni, Amy Shafrir, Leslie V Farland, Kathryn L Terry, Brian W Whitcomb, A Heather Eliassen, Elizabeth R Bertone-Johnson, Stacey A Missmer
Affiliations
- Department of Obstetrics, Gynecology, Reproductive Biology, College of Human Medicine, Michigan State University, East Lansing.
- Division of Adolescent and Young Adult Medicine, Department of Medicine, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
- Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, Tucson, Arizona.
- Department of Obstetrics and Gynecology, College of Medicine-Tucson, University of Arizona, Tucson.
- Obstetrics, Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst.
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
- Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts, Amherst.
- Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University, Grand Rapids.
Abstract
Importance
Early natural menopause (ENM) has been associated with reduced reproductive span, cardiovascular disease risk, and early mortality. The potential adverse implications of endometrioma surgery for ovarian reserve are known, yet the association of endometriosis with menopausal timing remains understudied.
Objective
To investigate the association between endometriosis and risk for ENM.
Design, Setting, and Participants
This large, population-based cohort study analyzed data from the Nurses' Health Study II cohort questionnaires from the 1989 to 2015 questionnaire cycles. The sample included premenopausal women aged 25 to 42 years at baseline or enrollment in 1989. Cumulative follow-up rate was greater than 90%, and participants continued follow-up until the onset of ENM, age 45 years, hysterectomy, oophorectomy, cancer diagnosis, death, loss to follow-up, or end of follow-up in May 2017, whichever occurred first. Data analyses were conducted from October 26, 2020, to April 27, 2021.
Exposures
Endometriosis diagnosis status was queried in the biennial questionnaires, with participants reporting physician diagnosis and whether the diagnosis was laparoscopically confirmed.
Main Outcomes and Measures
Natural menopause before age 45 years. Menopause status was assessed every 2 years.
Results
The study included 106 633 premenopausal women with a mean (SD) age of 34.8 (4.3) years at baseline, of whom 3921 reported a laparoscopically confirmed endometriosis diagnosis. During 1 508 462 person-years of follow-up, 6640 participants reported being diagnosed with endometriosis, 99 993 never reported endometriosis, and 2542 reported experiencing ENM. In the age- and calendar time-adjusted model, laparoscopically confirmed endometriosis was associated with a 50% greater risk for ENM (hazard ratio [HR], 1.51; 95% CI, 1.30-1.74). A similar risk was observed after adjusting for race and ethnicity and time-varying anthropometric and behavioral factors (HR, 1.46; 95% CI, 1.26-1.69). With additional adjustment for reproductive factors, the HR of ENM was attenuated but significant (HR, 1.28; 95% CI, 1.10-1.48). A greater risk of ENM was observed among women who were nulliparous after stratifying by parity (nulliparous vs parous: HR, 1.46 [95% CI, 1.15-1.86] vs 1.14 [95% CI, 0.94-1.39]; P for heterogeneity = .05) or who never used oral contraceptives when stratifying by oral contraceptive use (never vs ever: HR, 2.03 [95% CI, 1.34-3.06] vs 1.20 [95% CI, 1.02-1.42]; P for heterogeneity = .02). No significant differences were observed in the association between endometriosis and ENM when stratifying by body mass index (calculated as weight in kilograms divided by height in meters squared; <25 vs ≥25: HR, 1.20 [95% CI, 0.99-1.45] vs 1.43 [95% CI, 1.11-1.83; P for heterogeneity = .34), cigarette smoking status (never vs ever: HR, 1.36 [95% CI, 1.13-1.65] vs 1.11 [95% CI, 0.87-1.42]; P for heterogeneity = .57), or history of infertility attributed to ovulatory disorder (no vs yes: HR, 1.28 [95% CI, 1.08-1.51] vs 1.28 [95% CI, 0.90-1.82]; P for heterogeneity = .86).
Conclusions and Relevance
This cohort study found a risk for ENM in women with laparoscopically confirmed endometriosis. These women compared with those without endometriosis may be at a higher risk for shortened reproductive duration, particularly those who were nulliparous or never used oral contraceptives.
MeSH
Endometriosis, Cohort Studies, Contraceptives, Oral, Clinical Medicine, Diagnosis, Menopause, Contraceptive Agents
Cited by
- Endometriosis-associated infertility: From pathophysiology to tailored treatment. Front Endocrinol (Lausanne), 2022
- Clinical Management of Endometriosis in Menopause: A Narrative Review. Medicina (Kaunas), 2024
- Prevalence of Sex-Specific Cardiovascular Disease Risk Factors, Medical Risk, and Engagement in Health-Promoting Behaviours in Premenopausal Females. CJC Open, 2024
- Endometriosis and Mortality Risk in US Women: Findings From NHANES 1999-2006. Int J Womens Health, 2025
- Polygenic risk score phenome-wide association study reveals an association between endometriosis and testosterone. BMC Med, 2023
- Association between endometriosis and type and age of menopause: a pooled analysis of 279 948 women from five cohort studies. Hum Reprod, 2025
- Evidence on Serum Anti-Müllerian Hormone Levels and Endometriosis Surgery. J Clin Med, 2025
- Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis. Cell Death Dis, 2022